1. | introduction | |||
2. | Liver-Fas antibody-induced acute liver injury | Fas antigen is important in programmed cell death in the liver [Ogasawara J et al. Nature 364:806 (1993).] BH3-only proapoptotic protein, Bid, amplifies a weak death receptor signal in hepatocutes rendering the liver more sensitive to FasL-induced apoptosis [Schungel S et al. Hepatology 50:1558 (2009)]. |
||
3. | Liver-acetaminophen-induced acute liver injury | Acetaminophen (APAP) overdose leads to drug-induced liver damage. C-Jun N-terminal kinase (JNK) plays a major role to promote APAP-induced hepatotoxicity [Gunawan BK et al. Gastroenterology 131:165 (2006)]. Deletion of apoptosis signal-regulating kinase 1 (ASK1) attenuates APAP-induced liver injury by inhibiting JNK. ASK1 likely is involved in the liver damage by prolongation of JNK activation [Nakagawa H et al. Gastroenterology 135:1311 (2008)]. |
||
4. | Liver-steatohepatitis | Loss of B-catenin in the liver leads to defective cholesterol and bile acid metabolism in the liver and increased susceptibility to developing steatohepatitis in the face of metabolic stress [Behari J et al. Am J Pathol 176:744 (2010)]. | ||
6. | Liver-fibrosis-angiopoietin 1, angiotensin II | Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis [Taura K et al. Gastroenterology 135:1729 (2008)]. Angiotensin II activates IkB Kinase Phosphorylation of RelA at Ser536 to promote myofibroblast survival and liver fibrosis [Oakley F et al. Gastroenterology 136:2334 (2009)] |
||
7. | Liver-fibrosis-angiotensin II | Hepatic fibrogenesis requires sympathetic neurotransmitters [Oben JA et al. Gut 53:438 (2004)] HSC are hepatic neuroglia that produce and respond to SNS neurotransmitters to promote hepatic fibrosis. |
||
8. | Pancreas-a role of incretin receptor signaling in STZ-induced diabetes in mice | Differential importance of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide 1 receptor signaling for beta cell survival in mice [Maida A et al. Gastroenterology 137:2146 (2009)] There are functionally important differences in the pharmacologic and physiologic roles of incretin receptors in beta cells. GLP-1R signaling exerts more robust control of beta cell survival, relative to GIPR activation or dipeptidylpeptidase-4 inhibition in mice in vivo. |
||
9. | Pancreas-Hedgehog signaling in regeneration | Hedgehog Signaling Is Required for Effective Regeneration of Exocrine Pancreas [Fendrich V et al. Gastroenterology 135:621 (2008)] Using a model of cerulein-mediated injury and repair, this study demonstrates that mature exocrine cells actively contribute to regenerating pancreatic epithelium through formation of metaplastic ductal intermediates. Acinar cell regeneration is associated with activation of Hedgehog (Hh) signaling. |
||
10. | Pancreas-Notch signaling in a mouse model of pancreatic ductal adenocarcinoma | Inhibition of r-secretase activity inhibits tumor progression in a mouse model of pancreatic ductal adenocarcinoma [Plentz R et al. Gastroenterology 136:1741 (2009)] Expression of activated Kras (KrasGOF) in acinar cells leads to PanIN formation, which is accelerated in the presence of activated Notch. Loss of the tumor suppressor p53 (p53LOF) allows progression to invasive tumors, which can be repressed by blocking Notch signaling with a GSI. |
||
11. | Pancreas-Notch signaling in acinar-to-B-cell conversion | Notch signaling as gatekeeper of rat acinar-to-B-cell conversion in vitro [Baeyens L et al. Gastroenterology 136:1750 (2009)] Ductal metaplasia of cultured acinar cells can be directly induced by Notch, or indirectly (still requiring Notch function) by epidermal growth factor (EGF) receptor agonists. Cultured acinar cells can be efficiently forced to become functional B-cells, in the presence of EGF and leukemia inhibitory factor (LIF), by an initial activation of Notch (acinar-to-duct) followed by its inhibition (duct-to-B-cell). |
||
12. | Intestine-NOD2 null mice | Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract [Kobayashi KS et al. Science 307:731 (2005) ] Protective immunity mediated by Nod2 recognition of bacterial muramyl dipeptide is abolished in Nod2-deficient mice. These animals are susceptible to bacterial infection via the oral route but not through intravenous or peritoneal delivery. Nod2 is required for the expression of a subgroup of intestinal anti-microbial peptides, known as cryptdins. |
||
14. | Intestine-MyD88 null mice | Recognition of commensal microflora by Toll-Like Receptors is required for intestinal homeostasis [Rakoff-Nahoum et al. Cell 118:229 (2004)] Severe susceptibility to colonic injury in MyD88-deficient mice. TLR-mediated recognition of commensals in the colon regulates production of tissue protective factors. Commensal bacteria are recognized by TLRs under normal steady-state conditions, and this interaction plays a crucial role in the maintenance of intestinal epithelial homeostasis. |
||
15. | Intestine-TLR5 | Pathophysiological role of Toll-like receptor 5 engagement by bacterial flagellin in colonic inflammation [Rhee SH et al. PNAS 102:13610 (2005)] Flagellin TLR5 response is restricted to the basolateral apect of colonic mucosa. Flagellin exposure to the injured colonic mucosa induces in vivo activation of MEK1/2 in colonic mucosa. Flagellin exposed to injured colonic mucosa significantly aggravates the clinical symptoms of colitis. Flagellin exposure to injured colon causes apoptosis in colonic epithelium. |
||
16. | Intestine-EP2-PGE2 | Acceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcΔ716 knockout mice [Sonoshita M et al. Nat Med 7:1048 (2001)] Homozygous deletion of the gene encoding a cell-surface receptor of PGE2, EP2, causes decreases in number and size of intestinal polyps in ApcΔ716 mice (a mouse model for human familial adenomatous polyposis). This effect is similar to that of COX-2 gene disruption. Prostaglandin E2 Promotes Colon Cancer Cell Growth Through a Gs-Axin-b-Catenin Signaling Axis [Castellone MD et al. Science 310 :1504 (2005)] PGE2 stimulates colon cancer cell growth through its heterotrimeric guanine nucleotide-binding protein (G protein)–coupled receptor, EP2, by a signaling route that involves the activation of phosphoinositide 3-kinase and the protein kinase Akt by free G protein bg subunits and the direct association of the G protein as subunit with the regulator of G protein signaling (RGS) domain of axin. |
||
17. | Intestine-MUC2 | Muc2-Deficient Mice Spontaneously Develop Colitis, Indicating That Muc2 Is Critical for Colonic Protection [Van der Sluis M et al Gastroenterology 131:117 (2006)] Muc2 -/- mice showed clinical signs of colitis (as of 5 weeks), aggravating as the mice aged. Microscopic analysis of the colon of Muc2 / mice showed mucosal thickening, increased proliferation, and superficial erosions. |
||
18. | Lung-KRAS | Wildtype Kras2 can inhibit lung carcinogenesis in mice [Zhang Z et al. Nat Genet 29:25 (2001)] Mice with a heterozygous Kras2 deficiency were highly susceptible to the chemical induction of lung tumors when compared to wildtype mice. Wildtype Kras2 has tumor suppressor activity and is frequently lost during lung tumor progression. |
||
19. | Lung-EGFR | EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy [Paez JG et al. Science, 304::1497 (2004)] To determine whether mutation of receptor tyrosine kinases plays a causal role in NSCLC, somatic genetic alterations were searched in a set of 119 primary NSCLC tumors. Identified mutations were L858R in activation loop, G719S in P-loop and deletion mutants in exon 19. L858R mutant EGFR is particularly sensitive to inhibition by gefitinib compared with the wild-type enzyme. |
||
20. | 동물내의 질병발현 | 2011. 06. 14 | ||
21. | 동물내의 질병발현 |